Infect Chemother.  2010 Oct;42(5):296-298. 10.3947/ic.2010.42.5.296.

A Case of Septic Shock Caused by Escherichia coli after Intravenous Injection of Contaminated Propofol

• Kim YD
• Lee HK
• Jwa YJ
• Jung SK
• Um TH
• Cho CR
• Kwak YG

• KMID: 1806892
• DOI: http://doi.org/10.3947/ic.2010.42.5.296

Abstract

Propofol (2,6-diisopropylphenol) is a rapid and short-acting anesthetic agent that is used for general anesthesia and endoscopic sedation. It is available as an aqueous lipid emulsion and this preparation could serve as a bacterial culture medium. We report a case of a 46-year-old female who developed septic shock caused by Escherichia coli after being sedated by propofol to undergo gastrointestinal endoscopy. The contaminated propofol was identified as the cause of septic shock by pulsed-gel electrophoresis.

Keyword

Propofol; Escherichia coli; Septic shock

MeSH Terms

Anesthesia, General
Electrophoresis
Endoscopy, Gastrointestinal
Escherichia
Escherichia coli
Female
Humans
Injections, Intravenous
Middle Aged
Propofol
Shock, Septic
Propofol

Figure

• 

  Figure 1 Pulsed-field gel electrophoresis patterns of Escherichia coli isolates. Lane M, molecular weight standard; lane 1, propofol culture isolate, lane 2 blood culture isolate.

Reference

1. Heuss LT, Inauen W. The dawning of a new sedative: propofol in gastrointestinal endoscopy. Digestion. 2004. 69:20–26.

2. Crowther J, Hrazdil J, Jolly DT, Galbraith JC, Greacen M, Grace M. Growth of microorganisms in propofol, thiopental, and a 1:1 mixture of propofol and thiopental. Anesth Analg. 1996. 82:475–478.

3. Bennett SN, McNeil MM, Bland LA, Arduino MJ, Villarino ME, Perrotta DM, Burwen DR, Welbel SF, Pegues DA, Stroud L, Zeitz PS, Jarvis WR. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med. 1995. 333:147–154.

4. Crocker KS, Noga R, Filibeck DJ, Krey SH, Markovic M, Steffee WP. Microbial growth comparisons of five commercial parenteral lipid emulsions. JPEN J Parenter Enteral Nutr. 1984. 8:391–395.

5. Jarvis WR, Highsmith AK. Bacterial growth and endotoxin production in lipid emulsion. J Clin Microbiol. 1984. 19:17–20.

6. Tessler M, Dascal A, Gioseffini S, Miller M, Mendelson J. Growth curves of Staphylococcus aureus, Candida albicans, and Moraxella osloensis in propofol and other media. Can J Anaesth. 1992. 39:509–511.

7. Veber B, Gachot B, Bedos JP, Wolff M. Severe sepsis after intravenous injection of contaminated propofol. Anesthesiology. 1994. 80:712–713.

8. McHugh GJ, Roper GM. Propofol emulsion and bacterial contamination. Can J Anaesth. 1995. 42:801–804.

9. Muscarella LF. Infection control and its application to the administration of intravenous medications during gastrointestinal endoscopy. Am J Infect Control. 2004. 32:282–286.

10. Henry B, Plante-JenKin C, Ostrowska K. An outbreak of Serratia marcescens associated with the anesthetic agent propofol. Am J Infect Control. 2001. 29:312–315.

11. Nichols RL, Smith JW. Bacterial contamination of an anesthetic agent. N Engl J Med. 1995. 333:184–185.